Pacific Biosciences Of California | PACB - Operating Expenses


Pacific Biosciences Of California reported $97.83M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Agilent USD 1.44B 9M Mar/2026
Bruker USD 813.2M 87.7M Mar/2026
Danaher USD 52.58B 368M Jun/2026
General Electric Aerospace USD 17.64B 417M Jun/2026
Illumina USD 899M 47M Jun/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Quidel USD 1.85B 1.09B Mar/2026
Revvity USD 628.34M 2.12M Mar/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Standard Biotools USD 30.56M 15.16M Mar/2026
Thermo Fisher Scientific USD 9.81B 716M Jun/2026
Waters USD 1.12B 457.15M Mar/2026